You are here

Home » Content

Over Tümörlerinin Epidemiyolojik Özellikleri

EPIDEMIOLOGICAL FEATURES OF OVARIAN TUMOURS

Journal Name:

  • Türkiye Aile Hekimliği Dergisi

Publication Year:

  • 2002

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Our study aims to investigate retrospectively the epidemiolo-gical features of 80 patients diagnosed with ovarian cancer out of the 57584 patients who applied to the gynecology clinic of the izmir Atatürk Education and Research Hospital bet¬ween 1990-98 with various complaints. Our study reveals that the ratio of ovarian cancer among the patients who applied to our clinic was 0.1%; the cancer pati¬ents were in risk groups according to their menopause age, epithelial ovarian cancer was more frequent among the post-menopausal patients and, the patients who had a family his¬tory, of gynecologic cancer were younger. Considering the risk and preventive factors of ovarian consers, epidemiological studies must be put in agenda for public he¬alth.
Bookmark/Search this post with
Abstract (Original Language): 
Over kanserlerinin epidemiyolojik özelliklerini araştırmak amacı ile yaptığımız araştırmamızda izmir Atatürk Eğitim ve Araştırma Hastanesi 2. Kadın Hastalıkları ve Doğum Kliniği'ne 1990 ile 1998 yılları arasında başvuran 57584 hasta arasında over kanseri tanısı alan 80 hastanın epidemiyolojik özellikleri retrospek-tif olarak incelenmiştir. Çalışmamızda polikliniğimize başvuran hastaların %0.1'i over kanseri tanısı ile takip ve tedavi edilmiş olup, hastaların menopoz yaşları açısından over kanseri risk grubunda oldukları görülmüş, postmenopozal kadınlarda daha çok epiteliyal over kanserleri görülerek, ailesinde genital kanser öyküsü olanlarda hastalığın daha genç yaşlarda ortaya çıktığı saptanmıştır. Over kanserlerinde risk faktörlerinin ve koruyucu faktörlerin oynadığı rol göz önüne alınınca bu alanda yapılacak olan epi-demiyolojik çalışmaların arttırılması halk sağlığı açısından önemli bir gündem maddesi olarak karşımıza çıkmaktadır.
FULL TEXT (PDF): 
PDF icon arastrmx_116859_6_pp_24-28.pdf
  • 1
24-28
  • Turkish

REFERENCES

References: 

1. Parkin DM, Muir CS, Whelan SL ve ark. Cancer incidence in five continents. Lyon, IARC Scientific Publications 1992; 770-3.
2. Whittemore AS, Harris R, Itnyre J. The Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136(10): 1204-11.
3. Mant JWF, Vessey MP. Ovarian and endometrial cancers. Trends in Cancer'de. Ed. Doll R, Fraumeni JF Jr, Muir CS. Incidence and Mortality. Plainview. Cold Spring Harbor Laboratory Press 1994: 287-307.
4. Buell P, Dunn JE. Cancer mortality among Japanese Isseri and Niseri of California. Cancer 1965; 18: 656-64.
5. Kliewer EV, Smith KR. Ovarian cancer mortality among immigrants in Australia and Canada. Cancer Epidemiol Biomarkers Prev 1995; 4(5):
453-8.
6. Booth M, Beral V. The epidemiology of ovarian cancer. Ovarian Cancer'de. Ed. Hudson CN. Oxford, Oxford University Press 1985; 22-44.
7. Adami HO, Bergstrom R, Persson I, Sparen P. The incidence of ovarian cancer in Sweden, 1960-1984. Am J Epidemiol 1990; 132(3): 446-52.
8. Ewertz M, Kjaer SK. Ovarian cancer incidence and mortality in Denmark, 1943-1982. Int J Cancer 1988; 42(5): 690-6.
9. Amos CI, Struewing JP. Genetic epidemiology of epithelial ovarian cancer. Cancer 1993; 71(2 Suppl): 566-72.
10. Friedman LS, Ostermeyer EA, Lynch ED. The search for BRCA1. Cancer Res 1994; 54(24): 6374-82.
11. Gayther SA, Mangion J, Russell P ve ark. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA 2 gene. Nat Genet 1997; 15(1): 103-5.
1 2. Koch M, Gaedke H, Jenkins H. Family history of ovarian cancer pati¬ents: a case-control study. Int J Epidemiol 1989; 18(4): 782-5.
13. Franceschi S, La Vecchia C, Mangioni C. Familial ovarian cancer: eight more families. Gynecol Oncol 1982; 13(1): 31-6.
14. Lurian JR, Piver MS. Familial ovarian cancer. Gynecol Oncol 1979;
8(2): 185-92.
15. Rodriguez C, Calle EE, Coates RJ, Miracle-McMahill HL, Thun MJ, Heath CW Jr. Estrojen replacement therapy and fatal ovarian cancer. Am J Epidemiol 1995; 141(9): 828-35.
16. Purdie D, Green A, Bain C ve ark. Reproductive and other factors and risk of epithelial ovarian cancer. Int J Cancer 1995; 62(6): 678-84.
17. Risch HA, Marrett LD, Howe GR. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 1994; 140(7): 585¬97.
18. Harlow BL, Weiss NS, Roth GJ, Chu J, Daling JR. Case control study of borderline ovarian tumours: reproductive history and exposure to exo¬genous female hormones. Cancer Res 1988; 48(20): 5849-52.
19. Franceschi S, La Vecchia C, Booth M ve ark. Pooled analysis of 3 Eu¬ropean case-control stuties of ovarian cancer: II. Age at menarche and at
menopause. Int J Cancer1991; 49(1): 57-60.
20. Willett WC, Bain C, Hennekens CH, Rosner B, Speizer FE. Oral cont¬raceptives and risk of ovarian cancer. Cancer 1981; 48(7): 1684-7.
21. Annegers JF, Strom H, Decker DG, Dockerty MB, O'Fallon WM.
Ovarian cancer: incidence and case-control study. Cancer 1979; 43(2):
723-9.
22. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Deve¬lopment. The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Engl J Med 1987; 316(11): 650-5.
23. Weiss NS, Lyon JL, Liff JM, Vollmer WM, Daling JR. Incidence of
ovarian cancer in relation to the use of oral contraceptives. Int J Cancer
1981; 28(6): 669-71.
24. Brinton LA, Melton LJ 3rd, Malkasian GD Jr, Bond A, Hoover R.
Cancer risk after evaluation for infertility. Am J Epidemiol 1989; 129(4):
712-22.
25. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tu¬mors in a cohort of infertile women. N Engl J Med 1994; 331(12): 771-6.
26. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet
1995; 346(8981): 995-1000.

Thank you for copying data from http://www.arastirmax.com